Ruth Aponte-Wesson, DDS, MS, FACP, is a prosthodontist and maxillofacial prosthodontist, and serves as an associate professor in the Section of Oral Oncology and Maxillofacial Prosthodontics of the Department of Head and Neck Surgery at the University of Texas MD Anderson Cancer Center in Houston.
Newer targeted therapies are being linked with medication-related osteonecrosis of the jaw, which underscores the need to stay abreast of its risk factors and etiologies.